DK0723963T3 - 4-Amino-benzoylguanidin-derivater - Google Patents

4-Amino-benzoylguanidin-derivater

Info

Publication number
DK0723963T3
DK0723963T3 DK96100763T DK96100763T DK0723963T3 DK 0723963 T3 DK0723963 T3 DK 0723963T3 DK 96100763 T DK96100763 T DK 96100763T DK 96100763 T DK96100763 T DK 96100763T DK 0723963 T3 DK0723963 T3 DK 0723963T3
Authority
DK
Denmark
Prior art keywords
amino
benzoylguanidine derivatives
benzoylguanidine
derivatives
Prior art date
Application number
DK96100763T
Other languages
Danish (da)
English (en)
Inventor
Klaus-Otto Dr Minck
Manfred Dr Baumgarth
Rolf Dr Gericke
Norbert Dr Beier
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Application granted granted Critical
Publication of DK0723963T3 publication Critical patent/DK0723963T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • C07C317/44Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C07C317/48Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyridine Compounds (AREA)
DK96100763T 1995-01-28 1996-01-19 4-Amino-benzoylguanidin-derivater DK0723963T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19502644A DE19502644A1 (de) 1995-01-28 1995-01-28 4-Amino-benzoylguanidin-Derivate

Publications (1)

Publication Number Publication Date
DK0723963T3 true DK0723963T3 (da) 2001-09-24

Family

ID=7752517

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96100763T DK0723963T3 (da) 1995-01-28 1996-01-19 4-Amino-benzoylguanidin-derivater

Country Status (28)

Country Link
US (1) US5739142A (zh)
EP (1) EP0723963B1 (zh)
JP (1) JP3770946B2 (zh)
KR (1) KR100521853B1 (zh)
CN (1) CN1057999C (zh)
AR (1) AR002273A1 (zh)
AT (1) ATE202093T1 (zh)
AU (1) AU705632B2 (zh)
BR (1) BR9600217A (zh)
CA (1) CA2168192C (zh)
CO (1) CO4700428A1 (zh)
CZ (1) CZ289922B6 (zh)
DE (2) DE19502644A1 (zh)
DK (1) DK0723963T3 (zh)
ES (1) ES2158153T3 (zh)
FI (1) FI960376A (zh)
GR (1) GR3036572T3 (zh)
HU (1) HUP9600173A3 (zh)
NO (1) NO305793B1 (zh)
PL (1) PL182219B1 (zh)
PT (1) PT723963E (zh)
RU (1) RU2160728C2 (zh)
SI (1) SI0723963T1 (zh)
SK (1) SK281198B6 (zh)
TR (1) TR199600064A2 (zh)
TW (1) TW325463B (zh)
UA (1) UA56983C2 (zh)
ZA (1) ZA96629B (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4328352A1 (de) * 1993-08-24 1995-03-02 Hoechst Ag Substituierte N,N'-Di-benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19737463A1 (de) * 1997-08-28 1999-03-04 Hoechst Marion Roussel De Gmbh Verwendung von Inhibitoren des Natrium-Wasserstoff-Austauschers zur Herstellung eines Arzneimittels zur Behandlung von Erkrankungen, die durch Protozoen verursacht werden
ES2224620T3 (es) * 1998-03-23 2005-03-01 Aventis Pharmaceuticals Inc. Derivados de piperidinilo y n-aminopiperidinilo.
AU1553500A (en) * 1998-11-26 2000-06-13 Merck Patent Gmbh Use of benzoylguanidines for the treatment of non-insulin-dependent diabetes mellitus
DE19859727A1 (de) * 1998-12-23 2000-06-29 Aventis Pharma Gmbh Die Verwendung von Hemmern des Natrium-Wasserstoff-Austauschers zur Herstellung eines Medikaments zur Verhinderung von altersbedingten Organ-Dysfunktionen, altersbedingten Erkrankungen zur Lebensverlängerung
DE10023405A1 (de) * 2000-05-12 2001-11-15 Merck Patent Gmbh Verfahren zur Herstellung von Sulfonyl-benzoylguanidinum-Salzen
SA04250283B1 (ar) * 2003-09-26 2008-05-26 سولفاي فارماسيتيكالز جي أم بي أتش مشتقات من amidomethy1-substituted1-(carboxyalkyl)-cyclopentylcarbonylamino-benzazepine-N-acetic acid
DE102005030400A1 (de) * 2005-06-27 2006-12-28 Archimica Gmbh Verfahren zur Herstellung von Arylaminen, Arylethern und Arylthioethern

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3929582A1 (de) * 1989-09-06 1991-03-07 Hoechst Ag Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament
ATE147375T1 (de) * 1992-09-22 1997-01-15 Hoechst Ag Benzoylguanidine, verfahren zu ihrer herstellung, sowie ihre verwendung als antiarrhythmika
DE4328869A1 (de) * 1993-08-27 1995-03-02 Hoechst Ag Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Also Published As

Publication number Publication date
SI0723963T1 (en) 2002-08-31
TR199600064A2 (tr) 1996-08-21
EP0723963A1 (de) 1996-07-31
PL312490A1 (en) 1996-08-05
CN1057999C (zh) 2000-11-01
CA2168192A1 (en) 1996-07-29
CN1138575A (zh) 1996-12-25
HUP9600173A2 (en) 1997-01-28
AU705632B2 (en) 1999-05-27
DE19502644A1 (de) 1996-08-01
JP3770946B2 (ja) 2006-04-26
TW325463B (en) 1998-01-21
FI960376A (fi) 1996-07-29
RU2160728C2 (ru) 2000-12-20
KR960029319A (ko) 1996-08-17
PT723963E (pt) 2001-11-30
GR3036572T3 (en) 2001-12-31
BR9600217A (pt) 1998-01-06
US5739142A (en) 1998-04-14
ES2158153T3 (es) 2001-09-01
CZ25296A3 (en) 1997-03-12
NO960353L (no) 1996-07-29
ZA96629B (en) 1996-10-24
CA2168192C (en) 2008-07-29
JPH08269001A (ja) 1996-10-15
NO960353D0 (no) 1996-01-26
AR002273A1 (es) 1998-03-11
PL182219B1 (pl) 2001-11-30
SK12296A3 (en) 1996-09-04
UA56983C2 (uk) 2003-06-16
HUP9600173A3 (en) 1998-07-28
CZ289922B6 (cs) 2002-04-17
EP0723963B1 (de) 2001-06-13
CO4700428A1 (es) 1998-12-29
NO305793B1 (no) 1999-07-26
FI960376A0 (fi) 1996-01-26
DE59607054D1 (de) 2001-07-19
SK281198B6 (sk) 2001-01-18
KR100521853B1 (ko) 2006-06-16
AU4211296A (en) 1996-08-08
ATE202093T1 (de) 2001-06-15

Similar Documents

Publication Publication Date Title
DE69522717D1 (de) Chinazolinderivate
DE69611361D1 (de) Chinazolin-derivate
NO974103L (no) Arylsulfonylaminohydroksamsyre-derivater
DE69610698T2 (de) Chinazolin-derivate
PT833828E (pt) Derivados de rapamicina
DE69627551D1 (de) Lüftströmungssteuervorrichtung
BR9611834A (pt) Derivados de oximetóxi-3-aril-pirona
NO964667D0 (no) Purin-6-on-derivater
ATE199150T1 (de) Diphenylmethylenpiperidin-derivate
DE69601527T2 (de) Pyrrolylbenzimidazol-Derivate
ATA100695A (de) Prothrombin-derivate
DE69620054D1 (de) Kalzinierschachtsofen
PT856007E (pt) Derivados de ciclopeptidos
ATE240307T1 (de) Diarylalkenylamin-derivate
DE69627830D1 (de) Pyrazol-derivate
NO961404D0 (no) 4-indolylpiperazinyl-derivater
DE59607054D1 (de) 4-Amino-benzoylguanidin-Derivate
DE59610106D1 (de) Fluorbenzylether-Derivate
ATE177102T1 (de) Chromanderivate
ATE225347T1 (de) Aza-anthracyclinone-derivate
BR9603508A (pt) Derivados de alquenil-benzoilguanidina
ATE202088T1 (de) 4-mercapto-benzoylguanidin-derivate
DE69620514D1 (de) 5-aminoflavon-derivate
ATA45796A (de) Lysin-prolin-derivate
BR9603733A (pt) Derivados de cloropiridilcarbonila